Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}} Now: 1770522300811 Cache Key: cqdTagPageBySlug:car-t-cell-therapy-2 fetchCache[cqdTagPageBySlug:car-t-cell-therapy-2].expirationTime: falsey fetchCache[cqdTagPageBySlug:car-t-cell-therapy-2]. seconds remaining: falsey All fetchCache expiration times: -- Key: cqdNotFoundPage, seconds remaining: 6860 -- Key: cqdTagPageBySlug:patient-safety, seconds remaining: -16161 -- Key: cqdPostsByTag:cqd-migrated-tag-261,1,10, seconds remaining: -16092 -- Key: cqdTagPageBySlug:robotic-mitral-repair, seconds remaining: -13235 -- Key: cqdPostsByTag:cqd-migrated-tag-26457,1,10, seconds remaining: -13157 -- Key: cqdTagPageBySlug:adenoma-detection-rate, seconds remaining: -12902 -- Key: cqdPostsByTag:cqd-migrated-tag-21083,1,10, seconds remaining: -12836 -- Key: cqdTagPageBySlug:russell-demicco, seconds remaining: -11676 -- Key: cqdPostsByTag:cqd-migrated-tag-531,1,10, seconds remaining: -11604 -- Key: cqdTagPageBySlug:adenosine-triphosphate-atp, seconds remaining: -11325 -- Key: cqdPostsByTag:cqd-migrated-tag-8853,1,10, seconds remaining: -11246 -- Key: cqdTagPageBySlug:zong-ming-li, seconds remaining: -10965 -- Key: cqdPostsByTag:cqd-migrated-tag-4165,1,10, seconds remaining: -10891 -- Key: cqdTagPageBySlug:intracranial-aneurysms, seconds remaining: -10273 -- Key: cqdPostsByTag:cqd-migrated-tag-19155,1,10, seconds remaining: -10194 -- Key: cqdTagPageBySlug:sadashiva-karnik, seconds remaining: -7885 -- Key: cqdPostsByTag:cqd-migrated-tag-18385,1,10, seconds remaining: -7818 -- Key: cqdTagPageBySlug:parkinsons-disease, seconds remaining: -7477 -- Key: cqdPostsByTag:cqd-migrated-tag-16993,1,10, seconds remaining: -7324 -- Key: cqdTagPageBySlug:congenital-hypothyroidism, seconds remaining: -6937 -- Key: cqdPostsByTag:cqd-migrated-tag-4493,1,10, seconds remaining: -6882 -- Key: cqdTagPageBySlug:human-chorionic-gonadotropin-hcg, seconds remaining: -4723 -- Key: cqdPostsByTag:cqd-migrated-tag-24385,1,10, seconds remaining: -4675 -- Key: cqdTagPageBySlug:pain-education, seconds remaining: -4443 -- Key: cqdPostsByTag:cqd-migrated-tag-21121,1,10, seconds remaining: -4398 -- Key: cqdTagPageBySlug:lysosomal-storage-diseases, seconds remaining: -4229 -- Key: cqdPostsByTag:cqd-migrated-tag-24695,1,10, seconds remaining: -4178 -- Key: cqdTagPageBySlug:circulating-cell-free-dna-cfdna, seconds remaining: -3182 -- Key: cqdPostsByTag:cqd-migrated-tag-21977,1,10, seconds remaining: -3135 -- Key: cqdTagPageBySlug:liver-biopsy, seconds remaining: -2880 -- Key: cqdPostsByTag:cqd-migrated-tag-3646,1,10, seconds remaining: -2828 -- Key: cqdTagPageBySlug:james-church, seconds remaining: 6860 -- Key: cqdPostsByTag:cqd-migrated-tag-4620,1,10, seconds remaining: 6938 conditions: -- false, -- NA, -- NA, -- NA -- false Cache miss for key cqdTagPageBySlug:car-t-cell-therapy-2 - retrieving from Sanity CCCache.dataFetchCount: 14212 Cache cleanup seconds remaining: 3839
Advertisement
Advertisement
Minimal residual disease testing shows promising results
Research indicates strong rationale for expanding trial eligibility criteria
A New Standard of Care in Relapsed/Refractory Large B-Cell Lymphoma
Improving safety, efficacy and access for emerging therapies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Treatment may be a lifesaving option for patients with relapsed or refractory disease
A brief look at our programs
Preliminary trial reports positive patient response
Researching and operationalizing a new therapy
Molecular markers could potentially predict major adverse side effects
Rendered: Sun Feb 08 2026 03:45:00 GMT+0000 (Coordinated Universal Time)
9500 Euclid Avenue, Cleveland, Ohio 44195 |
800.223.2273 | ©
2026 Cleveland Clinic. All Rights Reserved.
Search
